Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).
Rydén
Lars
L
Department of Cardiology, Karolinska University Hospital, Sweden. lars.ryden@ki.se
Standl
Eberhard
E
Bartnik
Małgorzata
M
Van den Berghe
Greet
G
Betteridge
John
J
de Boer
Menko-Jan
MJ
Cosentino
Francesco
F
Jönsson
Bengt
B
Laakso
Markku
M
Malmberg
Klas
K
Priori
Silvia
S
Ostergren
Jan
J
Tuomilehto
Jaakko
J
Thrainsdottir
Inga
I
Vanhorebeek
Ilse
I
Stramba-Badiale
Marco
M
Lindgren
Peter
P
Qiao
Qing
Q
Priori
Silvia G
SG
Blanc
Jean-Jacques
JJ
Budaj
Andrzej
A
Camm
John
J
Dean
Veronica
V
Deckers
Jaap
J
Dickstein
Kenneth
K
Lekakis
John
J
McGregor
Keith
K
Metra
Marco
M
Morais
João
J
Osterspey
Ady
A
Tamargo
Juan
J
Zamorano
José Luis
JL
Deckers
Jaap W
JW
Bertrand
Michel
M
Charbonnel
Bernard
B
Erdmann
Erland
E
Ferrannini
Ele
E
Flyvbjerg
Allan
A
Gohlke
Helmut
H
Juanatey
Jose Ramon Gonzalez
JR
Graham
Ian
I
Monteiro
Pedro Filipe
PF
Parhofer
Klaus
K
Pyörälä
Kalevi
K
Raz
Itamar
I
Schernthaner
Guntram
G
Volpe
Massimo
M
Wood
David
D
D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D001145:Arrhythmias, Cardiac / Q000628:therapy; D001786:Blood Glucose / Q000378:metabolism; D003324:Coronary Artery Disease / Q000175:diagnosis / Q000628:therapy*; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis / Q000628:therapy*; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000628:therapy*; D003925:Diabetic Angiopathies / Q000175:diagnosis / Q000628:therapy*; D018450:Disease Progression; D005081:Exercise Therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006333:Heart Failure / Q000628:therapy; D006706:Homeostasis; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000517:prevention & control; D006973:Hypertension / Q000517:prevention & control; D009204:Myocardial Revascularization / Q000379:methods; D018570:Risk Assessment; D012307:Risk Factors; D012737:Sex Factors; D020521:Stroke / Q000517:prevention & control
D001786:Blood Glucose; D005343:Fibrinolytic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors